128 related articles for article (PubMed ID: 37987797)
21. Mebendazole as a Candidate for Drug Repurposing in Oncology: An Extensive Review of Current Literature.
Guerini AE; Triggiani L; Maddalo M; Bonù ML; Frassine F; Baiguini A; Alghisi A; Tomasini D; Borghetti P; Pasinetti N; Bresciani R; Magrini SM; Buglione M
Cancers (Basel); 2019 Aug; 11(9):. PubMed ID: 31480477
[TBL] [Abstract][Full Text] [Related]
22. Mebendazole stimulates CD14+ myeloid cells to enhance T-cell activation and tumour cell killing.
Rubin J; Mansoori S; Blom K; Berglund M; Lenhammar L; Andersson C; Loskog A; Fryknäs M; Nygren P; Larsson R
Oncotarget; 2018 Jul; 9(56):30805-30813. PubMed ID: 30112108
[TBL] [Abstract][Full Text] [Related]
23. A phase 2a clinical study on the safety and efficacy of individualized dosed mebendazole in patients with advanced gastrointestinal cancer.
Mansoori S; Fryknäs M; Alvfors C; Loskog A; Larsson R; Nygren P
Sci Rep; 2021 Apr; 11(1):8981. PubMed ID: 33903692
[TBL] [Abstract][Full Text] [Related]
24. In silico molecular target prediction unveils mebendazole as a potent MAPK14 inhibitor.
Ariey-Bonnet J; Carrasco K; Le Grand M; Hoffer L; Betzi S; Feracci M; Tsvetkov P; Devred F; Collette Y; Morelli X; Ballester P; Pasquier E
Mol Oncol; 2020 Dec; 14(12):3083-3099. PubMed ID: 33021050
[TBL] [Abstract][Full Text] [Related]
25. In Vitro and In Vivo Drug Interaction Study of Two Lead Combinations, Oxantel Pamoate plus Albendazole and Albendazole plus Mebendazole, for the Treatment of Soil-Transmitted Helminthiasis.
Cowan N; Vargas M; Keiser J
Antimicrob Agents Chemother; 2016 Oct; 60(10):6127-33. PubMed ID: 27480864
[TBL] [Abstract][Full Text] [Related]
26. Drug repurposing and relabeling for cancer therapy: Emerging benzimidazole antihelminthics with potent anticancer effects.
Nath J; Paul R; Ghosh SK; Paul J; Singha B; Debnath N
Life Sci; 2020 Oct; 258():118189. PubMed ID: 32781060
[TBL] [Abstract][Full Text] [Related]
27. Mebendazole for Differentiation Therapy of Acute Myeloid Leukemia Identified by a Lineage Maturation Index.
Li Y; Thomas D; Deutzmann A; Majeti R; Felsher DW; Dill DL
Sci Rep; 2019 Nov; 9(1):16775. PubMed ID: 31727951
[TBL] [Abstract][Full Text] [Related]
28. Cysticidal activity of praziquantel-mebendazole combination: In vitro and in vivo studies.
Francisca PA; Javier LF; Guadalupe PH; Fernanda GM; Nelly C; Helgi JC; Iliana GH; Susana RI
Acta Trop; 2020 Feb; 202():105238. PubMed ID: 31669532
[TBL] [Abstract][Full Text] [Related]
29. Mebendazole elicits potent antimyeloma activity by inhibiting the USP5/c-Maf axis.
Chen XH; Xu YJ; Wang XG; Lin P; Cao BY; Zeng YY; Wang Q; Zhang ZB; Mao XL; Zhang T
Acta Pharmacol Sin; 2019 Dec; 40(12):1568-1577. PubMed ID: 31197245
[TBL] [Abstract][Full Text] [Related]
30. Revisiting Non-Cancer Drugs for Cancer Therapy.
Yang EJ; Wu C; Liu Y; Lv J; Sup Shim J
Curr Top Med Chem; 2016; 16(19):2144-55. PubMed ID: 26881712
[TBL] [Abstract][Full Text] [Related]
31. HPMA Copolymer Mebendazole Conjugate Allows Systemic Administration and Possesses Antitumour Activity In Vivo.
Studenovský M; Rumlerová A; Kovářová J; Dvořáková B; Sivák L; Kostka L; Berdár D; Etrych T; Kovář M
Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745774
[TBL] [Abstract][Full Text] [Related]
32. Recent advances in drug repositioning for the discovery of new anticancer drugs.
Shim JS; Liu JO
Int J Biol Sci; 2014; 10(7):654-63. PubMed ID: 25013375
[TBL] [Abstract][Full Text] [Related]
33. Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update.
Chai JY; Jung BK; Hong SJ
Korean J Parasitol; 2021 Jun; 59(3):189-225. PubMed ID: 34218593
[TBL] [Abstract][Full Text] [Related]
34. In vivo dog intestinal precipitation of mebendazole: a basic BCS class II drug.
Carlert S; Akesson P; Jerndal G; Lindfors L; Lennernäs H; Abrahamsson B
Mol Pharm; 2012 Oct; 9(10):2903-11. PubMed ID: 22954025
[TBL] [Abstract][Full Text] [Related]
35. FDA approved drugs with antiviral activity against SARS-CoV-2: From structure-based repurposing to host-specific mechanisms.
Ahmed MS; Farag AB; Boys IN; Wang P; Menendez-Montes I; Nguyen NUN; Eitson JL; Ohlson MB; Fan W; McDougal MB; Mar K; Thet S; Ortiz F; Kim SY; Solmonson A; Williams NS; Lemoff A; DeBerardinis RJ; Schoggins JW; Sadek HA
Biomed Pharmacother; 2023 Jun; 162():114614. PubMed ID: 37068330
[TBL] [Abstract][Full Text] [Related]
36. Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme.
Bai RY; Staedtke V; Aprhys CM; Gallia GL; Riggins GJ
Neuro Oncol; 2011 Sep; 13(9):974-82. PubMed ID: 21764822
[TBL] [Abstract][Full Text] [Related]
37. Repurposing Mebendazole as a Replacement for Vincristine for the Treatment of Brain Tumors.
De Witt M; Gamble A; Hanson D; Markowitz D; Powell C; Al Dimassi S; Atlas M; Boockvar J; Ruggieri R; Symons M
Mol Med; 2017 Apr; 23():50-56. PubMed ID: 28386621
[TBL] [Abstract][Full Text] [Related]
38. Identification of oral therapeutics using an AI platform against the virus responsible for COVID-19, SARS-CoV-2.
Bess A; Berglind F; Mukhopadhyay S; Brylinski M; Alvin C; Fattah F; Wasan KM
Front Pharmacol; 2023; 14():1297924. PubMed ID: 38186640
[No Abstract] [Full Text] [Related]
39. Emerging insights on functions of the anthelmintic flubendazole as a repurposed anticancer agent.
Khachigian LM
Cancer Lett; 2021 Dec; 522():57-62. PubMed ID: 34520820
[TBL] [Abstract][Full Text] [Related]
40. Disulfiram and metformin combination anticancer effect reversible partly by antioxidant nitroglycerin and completely by NF-κB activator mebendazole in hamster fibrosarcoma.
Popović KJ; Popović DJ; Miljković D; Popović JK; Lalošević D; Poša M; Čapo I
Biomed Pharmacother; 2021 Nov; 143():112168. PubMed ID: 34536762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
